KaydedilenlerDerginizi ekleyin

Dergiler / Dicle Tıp Dergisi / 2026 / Cilt: 44 Sayı: 3

INH Direnç Mekanizmaları

Tanseli Gönlügür0000-0003-0751-6184
Ugur Gönlügür0000-0001-8720-2788
Sayfa
287–292
Yayın Tarihi
2017-09-20
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Bu d er l e m e y a zı s ı M y c o b ac t er i u m t u b er c u l osis ' de I N H e t k i m e ka n izm as ı n ı ve i la ç di re n c i n i n m o l e k ü l e r t e m e ll er i n i öz e t l e m e k t e d i r .

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Normal 0 21 false false false TR X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Normal Tablo"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} H e r n e ka d a r izo n i a zid ( I N H) ‘ ın M y c o b ac t e r ium t u b er c u l osis ü z er i n d e k i e t k i m e ka n i zm as ı t a m a n laş ı la m a mış o l s a da ö n c ü i la ç o la n I N H s it o p la zm a ya p as if d i füzyon i l e g i r m e k t e di r .
📊
Temel Bulgular & Veri:I N H ' a di r en çl i kl i n ik izo la t la r ın % 50 ' d e n f a z l as ı n da ka tG 31 5 . pozisyo n da s e r in y e r i n e t r e o n in ' i n d e ğişti ğ i b i r m u t as yon v a r dı r .
💡
Sonuç & Katkı:Bu d er l e m e y a zı s ı M y c o b ac t er i u m t u b er c u l osis ' de I N H e t k i m e ka n izm as ı n ı ve i la ç di re n c i n i n m o l e k ü l e r t e m e ll er i n i öz e t l e m e k t e d i r .
🔬Tür:Derleme
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:İzoniazid · direnç · mekanizma

Özet

Normal 0 21 false false false TR X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Normal Tablo"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} H e r n e ka d a r izo n i a zid ( I N H) ‘ ın M y c o b ac t e r ium t u b er c u l osis ü z er i n d e k i e t k i m e ka n i zm as ı t a m a n laş ı la m a mış o l s a da ö n c ü i la ç o la n I N H s it o p la zm a ya p as if d i füzyon i l e g i r m e k t e di r . KatG g en i t a r a f ı n d a n k od la n a n ka t ala z / p e r o ks id a z en z i mi i l e ak ti f le n m e k t e di r . I N H ‘ ı n ak ti f l en m e s i i l e s e r be s t m e t a b o l ik r a di kall e r o l u ş m ak t a , b un la r da mi k o l ik as it s en t e zi g i b i p e k ç ok h ücr e s e l f o n ks iyo n u b o z m ak t a dı r la r . KatG mut as yonl a r ı I N H di r en c i n in a n a seb eb i di r . I N H ' a di r en çl i kl i n ik izo la t la r ın % 50 ' d e n f a z l as ı n da ka tG 31 5 . pozisyo n da s e r in y e r i n e t r e o n in ' i n d e ğişti ğ i b i r m u t as yon v a r dı r . İnhA, n dh v e po m pa g e n le r i gi b i g e n l e r d e I N H d i r en c i n e ka t k ıda b u l un a b i l i r le r . Bu d er l e m e y a zı s ı M y c o b ac t er i u m t u b er c u l osis ' de I N H e t k i m e ka n izm as ı n ı ve i la ç di re n c i n i n m o l e k ü l e r t e m e ll er i n i öz e t l e m e k t e d i r .

🔖

Bu Makaleye Atıf Yap

Gönlügür, T., Gönlügür, U. (2017). INH Direnç Mekanizmaları. Dicle Tıp Dergisi, Cilt: 44 Sayı: 3, 287–292. https://doi.org/10.5798/dicletip.339020

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (21)

  1. Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol. 2016; 45:474-92.
  2. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998; 79:3-29.
  3. Heym B, Saint-Joanis B, Cole ST. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Tuber Lung Dis. 1999; 79:267-71.
  4. Nasiri MJ, Haeili M, Ghazi M, et al. New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria. Front Microbiol. 2017;8:681.
  5. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015. Int J Tuberc Lung Dis. 2015; 19:1276-89.
  6. Timmins GS, Deretic V. Mechanisms of action of isoniazid. Mol Microbiol. 2006; 62:1220-7.
  7. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev. 1995; 8:496–514.
  8. Cohn ML, Kovitz C, Oda U, Middlebrook G. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants. Am Rev Tuberc. 1954; 70:641-64.
  9. Almeida Da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother. 2011; 66:1417-30.
  10. Cade CE, Dlouhy AC, Medzihradszky KF, et al. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci.2010; 19:458-74.
  11. Rahim Z, Nakajima C, Raqib R, Zaman K, Endtz HP, van der Zanden AG, Suzuki Y. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh. Tuberculosis (Edinb). 2012; 92:529-34.
  12. Aslan G, Tezcan S, Serin MS, Emekdas G. Genotypic analysis of isoniazid and rifampin resistance in drug- resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey. Jpn J Infect Dis. 2008; 61:255-60.
  13. Barry CE 3rd, Slayden RA, Mdluli K. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis. Drug Resist Updat. 1998;1: 128-34. 14. Slayden RA, Barry CE 3rd. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Microbes Infect. 2000;2: 659-69.
  14. Pinheiro M, Silva AS, Pisco S, Reis S. Interactions of isoniazid with membrane models: implications for drug mechanism of action. Chem Phys Lipids. 2014;183:184-90.
  15. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun. 1996; 64:2062-9.
  16. Betts JC, Lukey PT, Robb LC, et al. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002; 43:717-31.
  17. Voskuil MI, Schnappinger D, Visconti KC, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med. 2003; 198:705-13.
  18. Lavollay M, Arthur M, Fourgeaud M, et al. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation. J Bacteriol. 2008;190:4360-6.
  19. Ramos RM, Perez JM, Baptista LA, de Amorim HL. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Myco- bacterium tuberculosis with isoniazid: a computational study on a new possible mechanism ofresistance. J Mol Model. 2012;18:4013-24.
  20. Zhang M, Yue J, Yang YP, et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2005;43:5477-82.
  21. Nandakumar M, Nathan C, Rhee KY. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat Commun. 2014; 5:4306.